CHARLOTTE, N.C. —While retailers remain cautious about selling hemp-based products, experts at CSP’s CBD & Convenience Retail conference shed more light on cannabidiol (CBD) and the growing category of medicinal remedies.
About 80 retailers and suppliers attended the event, held Oct. 28-30 in Charlotte, N.C., which featured topics ranging from legal issues to product quality. Talking about how the U.S. Food and Drug Administration (FDA) would want to handle CBD products, speaker Jonathan Havens of Saul Ewing Arnstein & Lehr LLP, Baltimore, said, “The FDA doesn’t want to regulate CBD, and if they do, it’s going to take years.”
The FDA would prefer the industry regulate itself, keeping in mind what’s best for the consumer, Havens said.
Meanwhile, the topic of hemp and CBDs continued to make news. Here’s a compilation of the most recent stories …
Agency would prefer industry regulates itself, CSP forum speaker says
Despite regulatory uncertainty, industry continues expansion
Growers must overcome hurdles to gain profitability
Policies reportedly touch on potency, quality control
About 60% of people seek relief from anxiety, but does it work?
More retailers exploring potential of medicinal remedy
Speakers explore potential of adding ingredient to consumer products
Members help make our journalism possible. Become a CSP member today and unlock exclusive benefits, including unlimited access to all of our content. Sign up here.